IP Library Granted Patent US 11,857,594
Granted Patent B2
US 11,857,594 · App. 17/968,788 · Granted Jan 2, 2024

Curcumin compositions and methods of use as an NK3 antagonist

Inventors: James R. Komorowski (Trumbull, CT); Sarah Sylla (Brooklyn, NY)
Assignee: JDS Therapeutics, LLC
A61K36/9066A61K31/26A61K36/82A61P15/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,857,594
App. No.
17/968,788
Granted
Jan 2, 2024
Kind
B2
Abstract

Disclosed herein are compositions for treating, ameliorating, preventing, or reducing the symptoms associated with menopause and/or hot flashes. The compositions disclosed herein comprise a curcumin composition, a green tea extract composition, and a phycocyanin composition that act as neurokinin 3 receptor antagonists. Also described herein are methods utilizing the aforementioned compositions.

Claims (12)

1. A combination composition comprising an amount of a curcumin composition, an amount of a green tea extract composition, and an amount of a phycocyanin composition, wherein the amount of the curcumin composition, the amount of the green tea extract composition, and the amount of the phycocyanin composition comprise a synergistic ratio.

2. The combination composition of claim 1 , wherein the synergistic ratio is about 6:3:1, curcumin composition to green tea extract composition to phycocyanin composition, respectively.

3. The combination composition of claim 1 , wherein the synergistic ratio is about 4.5:4.5:1, curcumin composition to green tea extract composition to phycocyanin composition, respectively.

4. The combination composition of claim 1 , wherein the synergistic ratio is about 7.2:1.8:1, curcumin composition to green tea extract composition to phycocyanin composition, respectively.

5. The combination composition of claim 1 , wherein the amount of the curcumin composition is about 100 mg to about 750 mg.

6. The combination composition of claim 1 , wherein the amount of the green tea extract composition is about 100 mg to about 500 mg.

7. The combination composition of claim 1 , wherein the amount of the phycocyanin composition is about 100 mg.

8. The combination composition of claim 1 , wherein when the combination composition is administered to a subject, the administration of the combination composition treats, ameliorates, or reduces symptoms associated with menopause in the subject.

9. The combination composition of claim 1 , wherein when the combination composition is administered to a subject, the administration of the combination composition treats, ameliorates, or reduces hot flashes, maintains a healthy level of hot flashes in the subject, or both.

10. The combination composition of claim 1 , wherein the combination composition is formulated as a dietary supplement or a pharmaceutical agent.

11. The combination composition of claim 1 , wherein the curcumin composition comprises a compound selected from the group consisting of diferuloylmethane, demethoxycurcumin, bis-demethoxycurcumin, tetrahydrocurcumin, dihydrocurcumin, hexahydrocurcumin, octohydrocurcumin, and any combination thereof.

12. The combination composition of claim 1 , wherein the green tea extract comprises a compound selected from the group consisting of epigallocatechin gallate, epicatechin, epigallocatechin, and epicatechin gallate, and any combination thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2023
From: JDS THERAPEUTICS, LLC
To: BONAFIDE HEALTH, LLC
Reel/Frame 065072/0787 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2023
From: KOMOROWSKI, JAMES R.; SYLLA, SARAH
To: JDS THERAPEUTICS, LLC
Reel/Frame 062709/0462 →
Continuity (2)
Provisional Application 63278989 · Nov 12, 2021
Related Publication 20230149499A1 · May 18, 2023